The FDA has approved guselkumab (Tremfya) as the first IL-23 inhibitor offering both subcutaneous and intravenous induction ...

The FDA expanded the approval of guselkumab (Tremfya) to include treatment of moderately to severely active Crohn's disease, drugmaker Johnson & Johnson announced on Thursday. An interleukin (IL)-23 ...

After being all-but written off a year ago, AstraZeneca’s anifrolumab has been reborn with new data that suggest it could help to end a drought in treatments for autoimmune disease systemic ...

Saphnelo (anifrolumab) is the first biologic drug ... Saphnelo is administered by intravenous infusion, like Benlysta when it was first launched, but GSK has since developed a formulation of ...

This includes comorbidities (e.g., diabetes, thyroid disorders), frequency of injection, cost, and/or age. Desired weight loss can also help narrow down the choice, as some options have a greater ...

The Kylaq and Syros are the most recent sub-4m SUVs in India that come with a lot of features and premium looks right from their base variants The steering wheel seen in the design patent is quite ...